Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Geovax Labs, Inc. (GOVX) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Geovax Labs, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 832489.
Total stock buying since 2007: $1,905,228.
Total stock sales since 2007: $661,018.
Total stock option exercises since 2007: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 32,800 | $33,884 | 0 | $0 | 0 | $0 |
| 2024 | 18,729 | $40,925 | 0 | $0 | 0 | $0 |
| 2023 | 101,684 | $58,185 | 0 | $0 | 0 | $0 |
| 2022 | 35,186 | $35,918 | 0 | $0 | 0 | $0 |
| 2020 | 245,603 | $1,228,015 | 0 | $0 | 0 | $0 |
| 2015 | 88,000 | $15,233 | 0 | $0 | 0 | $0 |
| 2012 | 45,000 | $30,150 | 0 | $0 | 0 | $0 |
| 2011 | 335,954 | $225,087 | 0 | $0 | 0 | $0 |
| 2010 | 59,625 | $206,466 | 700,000 | $104,735 | 0 | $0 |
| 2009 | 50,000 | $6,750 | 2,834,300 | $556,283 | 0 | $0 |
| 2008 | 75,000 | $9,675 | 0 | $0 | 0 | $0 |
| 2007 | 85,000 | $14,940 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-04 | 26,000 | $26,540 | 0 | $0 | 0 | $0 |
| 2025-03 | 6,800 | $7,344 | 0 | $0 | 0 | $0 |
| 2024-08 | 8,000 | $15,600 | 0 | $0 | 0 | $0 |
| 2024-02 | 10,729 | $25,325 | 0 | $0 | 0 | $0 |
| 2023-12 | 6,944 | $2,499 | 0 | $0 | 0 | $0 |
| 2023-09 | 9,653 | $5,019 | 0 | $0 | 0 | $0 |
| 2023-08 | 45,087 | $25,179 | 0 | $0 | 0 | $0 |
| 2023-04 | 40,000 | $25,488 | 0 | $0 | 0 | $0 |
| 2022-09 | 10,000 | $11,000 | 0 | $0 | 0 | $0 |
| 2022-07 | 1,000 | $820 | 0 | $0 | 0 | $0 |
| 2022-06 | 14,464 | $17,099 | 0 | $0 | 0 | $0 |
| 2022-05 | 9,722 | $6,999 | 0 | $0 | 0 | $0 |
| 2020-09 | 245,603 | $1,228,015 | 0 | $0 | 0 | $0 |
| 2015-05 | 10,000 | $1,890 | 0 | $0 | 0 | $0 |
| 2015-04 | 78,000 | $13,343 | 0 | $0 | 0 | $0 |
| 2012-01 | 45,000 | $30,150 | 0 | $0 | 0 | $0 |
| 2011-12 | 335,954 | $225,087 | 0 | $0 | 0 | $0 |
| 2010-07 | 1,000 | $2,500 | 0 | $0 | 0 | $0 |
| 2010-06 | 25,206 | $83,254 | 0 | $0 | 0 | $0 |
| 2010-05 | 33,419 | $120,712 | 0 | $0 | 0 | $0 |
| 2010-01 | 0 | $0 | 700,000 | $104,735 | 0 | $0 |
| 2009-12 | 0 | $0 | 500,000 | $69,650 | 0 | $0 |
| 2009-09 | 0 | $0 | 1,635,000 | $342,434 | 0 | $0 |
| 2009-08 | 50,000 | $6,750 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-10 | Sharkey John W. (VP, Business Development) | Buy | 6,000 | .99 | 5,940 |
| 2025-04-10 | Spencer John N Jr (Director) | Buy | 10,000 | .98 | 9,800 |
| 2025-04-01 | Dodd David A (President, CEO) | Buy | 10,000 | 1.08 | 10,800 |
| 2025-03-31 | Reynolds Mark (CFO) | Buy | 6,800 | 1.08 | 7,344 |
| 2024-08-09 | Dodd David A (President, CEO) | Buy | 8,000 | 1.95 | 15,600 |
| 2024-02-22 | Dodd David A (President, CEO) | Buy | 8,209 | 2.27 | 18,667 |
| 2024-02-21 | Dodd David A (President, CEO) | Buy | 520 | 2.15 | 1,118 |
| 2024-02-07 | Reynolds Mark (CFO) | Buy | 2,000 | 2.77 | 5,540 |
| 2023-12-22 | Mckee Kelly T. Jr. (Chief Medical Officer) | Buy | 6,944 | .36 | 2,499 |
| 2023-09-25 | Mckee Kelly T. Jr. (Chief Medical Officer) | Buy | 9,653 | .52 | 5,019 |
| 2023-08-25 | Dodd David A (President, CEO) | Buy | 35,087 | .57 | 19,999 |
| 2023-08-18 | Reynolds Mark (CFO) | Buy | 10,000 | .52 | 5,180 |
| 2023-04-24 | Dodd David A (President, CEO) | Buy | 32,000 | .64 | 20,448 |
| 2023-04-20 | Reynolds Mark (CFO) | Buy | 8,000 | .63 | 5,040 |
| 2022-09-21 | Chase Randal D (Director) | Buy | 10,000 | 1.10 | 11,000 |
| 2022-07-01 | Sharkey John W. (VP, Business Development) | Buy | 1,000 | .82 | 820 |
| 2022-06-27 | Mckee Kelly T. Jr. (Chief Medical Officer) | Buy | 4,464 | 1.12 | 4,999 |
| 2022-06-21 | Chase Randal D (Director) | Buy | 10,000 | 1.21 | 12,100 |
| 2022-05-05 | Mckee Kelly T. Jr. (Chief Medical Officer) | Buy | 9,722 | .72 | 6,999 |
| 2020-09-29 | Kollintzas Dean G (Director) | Buy | 11,987 | 5.00 | 59,935 |
| 2020-09-29 | Reynolds Mark (CFO) | Buy | 60,184 | 5.00 | 300,920 |
| 2020-09-29 | Spencer John N Jr (Director) | Buy | 21,024 | 5.00 | 105,120 |
| 2020-09-29 | Dodd David A (President, CEO) | Buy | 81,870 | 5.00 | 409,350 |
| 2020-09-29 | Chase Randal D (Director) | Buy | 16,613 | 5.00 | 83,065 |
| 2020-09-29 | Mcnally Robert T (Director) | Buy | 53,925 | 5.00 | 269,625 |
| 2015-05-05 | Chase Randal D (Director) | Buy | 10,000 | .19 | 1,890 |
| 2015-04-23 | Reynolds Mark (CFO) | Buy | 10,000 | .18 | 1,780 |
| 2015-04-22 | Reynolds Mark (CFO) | Buy | 20,000 | .17 | 3,439 |
| 2015-04-20 | Spencer John N Jr (Director) | Buy | 18,000 | .17 | 3,024 |
| 2015-04-20 | Chase Randal D (Director) | Buy | 30,000 | .17 | 5,100 |
| 2012-01-31 | Reynolds Mark (CFO) | Buy | 15,000 | .67 | 10,050 |
| 2012-01-16 | Antebi Steven S. (Director) | Buy | 30,000 | .67 | 20,100 |
| 2011-12-30 | Kollintzas Dean G (Director) | Buy | 14,925 | .67 | 9,999 |
| 2011-12-30 | Robinson Harriet L (Chief Scientific Officer) | Buy | 149,254 | .67 | 100,000 |
| 2011-12-30 | Reynolds Mark (CFO) | Buy | 15,000 | .67 | 10,050 |
| 2011-12-30 | Spencer John N Jr (Director) | Buy | 14,925 | .67 | 9,999 |
| 2011-12-30 | Dodd David A (Director) | Buy | 112,000 | .67 | 75,040 |
| 2011-12-30 | Mcnally Robert T (President/CEO) | Buy | 29,850 | .67 | 19,999 |
| 2010-07-02 | Reynolds Mark (Chief Financial Officer) | Buy | 1,000 | 2.50 | 2,500 |
| 2010-06-11 | Newman Mark J (VP, Research & Development) | Buy | 3,000 | 3.29 | 9,855 |
| 2010-06-10 | Robinson Harriet L (Chief Scientific Officer) | Buy | 5,100 | 3.33 | 16,935 |
| 2010-06-10 | Mcnally Robert T (President & CEO) | Buy | 300 | 3.30 | 990 |
| 2010-06-09 | Hildebrand Donald G (Director) | Buy | 1,000 | 3.29 | 3,290 |
| 2010-06-09 | Reynolds Mark (Chief Financial Officer) | Buy | 2,104 | 3.33 | 7,000 |
| 2010-06-09 | Mcnally Robert T (President & CEO) | Buy | 1,000 | 3.31 | 3,310 |
| 2010-06-08 | Robinson Harriet L (Chief Scientific Officer) | Buy | 400 | 3.23 | 1,290 |
| 2010-06-08 | Dodd David A (Director) | Buy | 4,702 | 3.25 | 15,257 |
| 2010-06-08 | Mcnally Robert T (President & CEO) | Buy | 1,000 | 3.25 | 3,250 |
| 2010-06-04 | Robinson Harriet L (Chief Scientific Officer) | Buy | 3,000 | 3.30 | 9,900 |
| 2010-06-03 | Robinson Harriet L (Chief Scientific Officer) | Buy | 500 | 3.31 | 1,652 |
| 2010-06-01 | Mcnally Robert T (President & CEO) | Buy | 1,000 | 3.49 | 3,490 |
| 2010-05-21 | Tsolinas Peter M (Director) | Buy | 2,000 | 4.10 | 8,200 |
| 2010-05-21 | Dodd David A (Director) | Buy | 8,365 | 3.90 | 32,598 |
| 2010-05-21 | Mcnally Robert T (President & CEO) | Buy | 2,000 | 4.08 | 8,150 |
| 2010-05-20 | Reynolds Mark (Chief Financial Officer) | Buy | 796 | 3.60 | 2,865 |
| 2010-05-20 | Spencer John N Jr (Director) | Buy | 10,100 | 3.33 | 33,633 |
| 2010-05-20 | Dodd David A (Director) | Buy | 2,658 | 3.46 | 9,191 |
| 2010-05-20 | Mcnally Robert T (President & CEO) | Buy | 2,000 | 3.80 | 7,600 |
| 2010-05-19 | Mcnally Robert T (President & CEO) | Buy | 1,000 | 3.40 | 3,400 |
| 2010-05-18 | Reynolds Mark (Chief Financial Officer) | Buy | 3,000 | 3.35 | 10,050 |
| 2010-01-27 | Emory University (10% Owner) | Sale | 50,000 | .14 | 7,149 |
| 2010-01-26 | Emory University (10% Owner) | Sale | 40,000 | .14 | 5,760 |
| 2010-01-25 | Emory University (10% Owner) | Sale | 35,000 | .14 | 5,040 |
| 2010-01-21 | Emory University (10% Owner) | Sale | 25,000 | .15 | 3,649 |
| 2010-01-20 | Emory University (10% Owner) | Sale | 25,000 | .15 | 3,649 |
| 2010-01-19 | Emory University (10% Owner) | Sale | 25,000 | .14 | 3,624 |
| 2010-01-14 | Emory University (10% Owner) | Sale | 52,500 | .14 | 7,559 |
| 2010-01-13 | Emory University (10% Owner) | Sale | 10,000 | .14 | 1,450 |
| 2010-01-12 | Emory University (10% Owner) | Sale | 35,000 | .15 | 5,285 |
| 2010-01-11 | Emory University (10% Owner) | Sale | 50,000 | .15 | 7,600 |
| 2010-01-08 | Emory University (10% Owner) | Sale | 135,000 | .14 | 19,575 |
| 2010-01-07 | Emory University (10% Owner) | Sale | 45,000 | .15 | 6,795 |
| 2010-01-06 | Emory University (10% Owner) | Sale | 65,000 | .16 | 10,400 |
| 2010-01-05 | Emory University (10% Owner) | Sale | 32,500 | .16 | 5,200 |
| 2010-01-04 | Emory University (10% Owner) | Sale | 75,000 | .16 | 12,000 |
| 2009-12-30 | Emory University (10% Owner) | Sale | 110,000 | .14 | 15,290 |
| 2009-12-29 | Emory University (10% Owner) | Sale | 180,000 | .14 | 25,020 |
| 2009-12-28 | Emory University (10% Owner) | Sale | 50,000 | .14 | 7,000 |
| 2009-12-22 | Emory University (10% Owner) | Sale | 60,000 | .14 | 8,340 |
| 2009-12-21 | Emory University (10% Owner) | Sale | 100,000 | .14 | 14,000 |
| 2009-09-30 | Emory University (10% Owner) | Sale | 175,000 | .17 | 30,274 |
| 2009-09-29 | Emory University (10% Owner) | Sale | 360,000 | .18 | 64,440 |
| 2009-09-28 | Emory University (10% Owner) | Sale | 220,000 | .19 | 42,680 |
| 2009-09-25 | Emory University (10% Owner) | Sale | 880,000 | .23 | 205,040 |
| 2009-08-24 | Spencer John N Jr (Director) | Buy | 50,000 | .14 | 6,750 |
| 2009-07-01 | Robinson Harriet L (SVP, Research & Development) | Sale | 15,000 | .19 | 2,805 |
| 2009-06-30 | Robinson Harriet L (SVP, Research & Development) | Sale | 42,000 | .18 | 7,728 |
| 2009-06-29 | Robinson Harriet L (SVP, Research & Development) | Sale | 45,000 | .18 | 8,325 |
| 2009-06-26 | Robinson Harriet L (SVP, Research & Development) | Sale | 161,000 | .18 | 29,785 |
| 2009-06-25 | Robinson Harriet L (SVP, Research & Development) | Sale | 125,000 | .20 | 24,625 |
| 2009-06-24 | Robinson Harriet L (SVP, Research & Development) | Sale | 202,000 | .21 | 42,824 |
| 2009-06-23 | Robinson Harriet L (SVP, Resarch & Development) | Sale | 49,100 | .25 | 12,275 |
| 2009-06-22 | Robinson Harriet L (SVP, Resarch & Development) | Sale | 60,200 | .26 | 15,832 |
| 2008-04-03 | Spencer John N Jr (Director) | Buy | 75,000 | .13 | 9,675 |
| 2007-12-06 | Reynolds Mark (Chief Financial Officer) | Buy | 30,000 | .17 | 5,040 |
| 2007-12-04 | Spencer John N Jr (Director) | Buy | 55,000 | .18 | 9,900 |
Insider trading activities including stock purchases, stock sales, and option exercises of GOVX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Geovax Labs, Inc. (symbol GOVX, CIK number 832489) see the Securities and Exchange Commission (SEC) website.